| Literature DB >> 34986037 |
Pouneh Amir Yazdani1,2,3,4, Marie-Lou St-Jean1,2,3,5, Sara Matovic1,2,3, Aaron Spahr1,2,3, Luan T Tran1,2,3, Renée-Myriam Boucher6, Chantal Poulin2,3, Bradley Osterman2,3, Myriam Srour1,2,3, Bernard Rosenblatt2,3, Sébastien Chenier7, Jean-Francois Soucy8,9, Anne-Marie Laberge8,9, Nancy Braverman1,3,10,11,12, Maria Daniela D'Agostino10,12, Cam-Tu Emilie Nguyen13, Maxime Morsa5,14, Geneviève Bernard1,2,3,10,12.
Abstract
Parents of children with genetically determined leukoencephalopathies play a major role in their children's health care. Because of the COVID-19 pandemic, many health care services were suspended, delayed or delivered remotely with telemedicine. We sought to explore the experience of parents of children with genetically determined leukoencephalopathies during the pandemic given the adapted health care services. We conducted semistructured interviews with 13 parents of 13 affected children. Three main themes were identified using thematic analysis: perceived impact of COVID-19 on health care services, benefits and challenges of telemedicine, and expectations of health care after the pandemic. Parents perceived a loss/delay in health care services while having a positive response to telemedicine. Parents wished telemedicine would remain in their care after the pandemic. This is the first study assessing the impact of COVID-19 on health care services in this population. Our results suggest that parents experience a higher level of stress owing to the shortage of services and the children's vulnerability.Entities:
Keywords: COVID-19 pandemic; leukodystrophy; pediatrics; quality of life
Mesh:
Year: 2022 PMID: 34986037 PMCID: PMC9066235 DOI: 10.1177/08830738211065317
Source DB: PubMed Journal: J Child Neurol ISSN: 0883-0738 Impact factor: 2.363
Parents and Patients Demographics.
| Serial number | Gender | Age | Child's age | Child's sex | Child's diagnosis |
|---|---|---|---|---|---|
| 1 | Female | 42 | 17 | Female | Alexander disease |
| 2 | Female | 52 | 15 | Female | Sialic acid storage disease |
| 22 | Female | Sialic acid storage disease | |||
| 3 | Female | 38 | 5 | Male | Aicardi-Goutières syndrome |
| 4 | Male | 39 | |||
| 5 | Male | 56 | 23 | Female | Aicardi-Goutières syndrome |
| 6 | Female | 54 | |||
| 7 | Female | 38 | 6 | Male | X-Linked Adrenoleukodystrophy |
| 8 | Female | 44 | 9 | Female | Cockayne syndrome |
| 9 | Female | 37 | 3 | Male | X-linked adrenoleukodystrophy |
| 10 | Male | 42 | 6 | Female | Leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) |
| 11 | Male | 45 | 13 | Male | Allan-Herndon-Dudley syndrome |
| 12 | Female | 38 | 13 | Male | Peroxisome biogenesis disorder/Zellweger spectrum disorder-PEX16 |
| 7 | Female | Peroxisome biogenesis disorder/Zellweger spectrum disorder-PEX16 | |||
| 13 | Female | 36 | 7 | Male | Undiagnosed gLE |
gLE, genetically determined leukoencephalopathy.
Themes, Subthemes, and Codes.
| Themes | Subthemes | Codes |
|---|---|---|
| Perceived impacts of the pandemic on received health care services | Delays and losses in services | Cancelled appointments; prolonged waiting time for services; loss of home care support; loss of school-related services; parental decision to delay services for the safety of their family |
| Benefits and challenges with telemedicine and technology in health care | Methods of telemedicine | Appointment settings; caregivers involved; child's presence |
| Expectations of health care after the COVID-19 pandemic | Suggestions for long-term changes in their care | Desire of implementing telemedicine in their child's long-term care |
gLE, genetically determined leukoencephalopathy.